FDA Clears Anticlotting Drug Eliquis

The Food and Drug Administration has granted approval for the next-generation anticlotting medication Eliquis, the regulator announced in a news release. The drug, administered in the form of a pill, is used to reduce stroke risk and fight clotting in patients with atrial fibrillation. This is a common variety of abnormal heart rhythm.

Eliquis has been developed jointly by Pfizer (NYSE: PFE  ) and Bristol-Myers Squibb (NYSE: BMY  ) .

The new drug is seen as a replacement for wafarin, the current standard treatment for the disorder. It is difficult to determine the precise dose for wafarin, however, and the side effects can be extreme. 

It is estimated that over 3 million people in the U.S. and around 8 million throughout the world suffer from atrial fibrillation. It is one of the top causes of stroke. 


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2172432, ~/Articles/ArticleHandler.aspx, 10/1/2014 8:52:09 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement